Why you can’t find Wegovy, the weight-loss drug

wsj
PETER LOFTUS, The Wall Street Journal
REUTERSPremium
REUTERS

Novo Nordisk A/S flubbed the launch of its buzzy new weight-loss drug Wegovy, missing out on hundreds of millions of dollars in sales and squandering a head start before a rival could begin selling a competing product.